Virtual Event | September 13, 2022

Comparability Assessment Protocols

Source: Cytiva

Certain CMC changes require comparability assessments, others don’t. But if you promise one, regulators will hold you to it whether required or not. In this segment of the Bioprocess Online Live event Regulatory Harmonization Meets CMC Realities, former Pfizer Head of Business Strategy and Operations and current CEO of InScope Coaching & Consulting Steffi Pluschkell, Ph.D. and Alira Health Senior VP of CMC Steven Chamow, Ph.D. discuss when comparability assessments are truly necessitated.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva